Conformis, Inc. to Present at the Oppenheimer MedTech, Tools & Diagnostics Summit
May 18 2021 - 8:15AM
Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device
company that features personalized knee and hip replacement
products, announced today that Mark Augusti, Chief Executive
Officer, will present at the Oppenheimer MedTech, Tools &
Diagnostics Summit.
A webcast of the virtual presentation will be made available on
the day of the summit, Wednesday, May 26, 2021.
Conformis management will also be available for one-on-one
meetings throughout the summit. For more information about the
conference or to schedule a one-on-one meeting with management,
please contact your Oppenheimer representative or Conformis
Investor Relations at ir@conformis.com and (781) 374-5598.
The replay of the webcast of the presentation will be archived
on Conformis' website for 30 days following the presentation under
"Events and Presentations" in the Investors section of the
Conformis website at ir.conformis.com.
About Conformis, Inc.
Conformis is a medical technology company that uses its
proprietary iFit® Image-to-Implant® technology platform to develop,
manufacture, and sell joint replacement implants and instruments
that are individually sized and shaped, which we refer to as
personalized, individualized, or sometimes as customized, to fit
and conform to each patient’s unique anatomy. Conformis offers
a broad line of sterile, personalized knee and hip implants and
single-use instruments delivered to hospitals and ambulatory
surgical centers. Conformis owns or exclusively in-licenses issued
patents and pending patent applications that cover personalized
implants and patient-specific instrumentation for all major
joints.
For more information, visit www.comformis.com. To receive future
releases in e-mail alerts, sign up at ir.conformis.com.
Investor Contact:
ir@conformis.com
(781) 374-5598
Conformis (NASDAQ:CFMS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Conformis (NASDAQ:CFMS)
Historical Stock Chart
From Sep 2023 to Sep 2024